DVC1-0101 to Treat Peripheral Arterial Disease: A Phase I/IIa Open-label Dose-escalation Clinical Trial

We here report the results of a Phase I/IIa open-label four dose-escalation clinical study assessing the safety, tolerability, and possible therapeutic efficacy of a single intramuscular administration of DVC1-0101, a new gene transfer vector based on a nontransmissible recombinant Sendai virus (rSe...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Yonemitsu, Yoshikazu, Matsumoto, Takuya, Itoh, Hiroyuki, Okazaki, Jin, Uchiyama, Makiko, Yoshida, Kumi, Onimaru, Mitsuho, Onohara, Toshihiro, Inoguchi, Hiroyuki, Kyuragi, Ryoichi, Shimokawa, Mototsugu, Ban, Hiroshi, Tanaka, Michiko, Inoue, Makoto, Shu, Tsugumine, Hasegawa, Mamoru, Nakanishi, Yoichi, Maehara, Yoshihiko
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2013
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3589164/
https://ncbi.nlm.nih.gov/pubmed/23319060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.279
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items